AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Q32 Bio Inc. Director's Dealing 2023

Dec 11, 2023

34891_dirs_2023-12-11_b7009054-7393-4932-ad09-e9ff743137df.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: Homology Medicines, Inc. (FIXX)
CIK: 0001661998
Period of Report: 2023-11-15

Reporting Person: Michaud Charles Jr (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	9066	Direct

Footnotes

F1: This amended Form 3 is being filed to correct the aggregate common stock holdings of the Reporting Person. On November 15, 2023, the Reporting Person filed a Form 3 that inadvertently omitted Employee Stock Purchase Plan ("ESPP") shares. Accordingly, the common stock holdings in column 5 of Table I have been increased by 6,954 ESPP shares.